Added to YB: 2026-04-09
Pitch date: 2026-04-07
IRIX [bullish]
IRIDEX Corporation
-7.21%
current return
Author Info
Company Info
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology.
Market Cap
$17.2M
Pitch Price
$1.11
Price Target
N/A
Dividend
N/A
EV/EBITDA
-21.57
P/E
-3.80
EV/Sales
0.41
Sector
Health Care Equipment and Supplies
Category
turnaround
A Primer on Iridex
IRIX: Ophthalmic med-tech w/ retina (71% rev) & glaucoma (29% rev) units both growing. Q4/25 adj EBITDA & FCF turned positive after 22% OpEx cut; more cost-cutting via contract mfg by FY27. EU MDR cert expected 2026 to unlock PASCAL upgrade cycle. FY26 guide $51-53M (+1-5%) ex-Middle East. 0.29x EV/S on $15M EV. Consistent insider buying. Upside from aging pop, diabetes rise (700M by 2045), 80-100M glaucoma addressable mkt.
Read full article (4 min)